$185 Million is the total value of JW Asset Management, LLC's 17 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CGC | CANOPY GROWTH CORP | $62,804,000 | +66.1% | 1,291,201 | 0.0% | 33.89% | +40.5% | |
| AMZN | AMAZON COM INC | $39,313,000 | +17.8% | 19,627 | 0.0% | 21.21% | -0.3% | |
| EGRX | EAGLE PHARMACEUTICALS INC | $32,984,000 | -8.4% | 475,755 | 0.0% | 17.80% | -22.4% | |
| CRON | CRONOS GROUP INC | $12,351,000 | +70.4% | 1,111,444 | 0.0% | 6.66% | +44.2% | |
| PETQ | PETIQ INC | $5,851,000 | +46.3% | 148,855 | 0.0% | 3.16% | +23.9% | |
| HZNP | HORIZON PHARMA PLC | $5,302,000 | +18.2% | 270,775 | 0.0% | 2.86% | +0.1% | |
| MSFT | MICROSOFT CORP | $4,746,000 | +16.0% | 41,500 | 0.0% | 2.56% | -1.8% | |
| BSTC | BIOSPECIFICS TECHNOLOGIES CO | $4,308,000 | +30.4% | 73,649 | 0.0% | 2.32% | +10.4% | |
| LGND | LIGAND PHARMACEUTICALS INC | $3,678,000 | +32.5% | 13,401 | 0.0% | 1.98% | +12.1% | |
| AVDL | AVADEL PHARMACEUTICALS PLCsponsored adr | $1,951,000 | -28.4% | 444,439 | 0.0% | 1.05% | -39.4% | |
| NVLNF | NOVELION THERAPEUTICS INC | $935,000 | -19.6% | 315,979 | 0.0% | 0.50% | -31.8% | |
| ALIM | ALIMERA SCIENCES INC | $405,000 | +0.2% | 413,300 | 0.0% | 0.22% | -15.1% | |
| OSTK | OVERSTOCK COM INC DEL | $277,000 | -17.8% | 10,000 | 0.0% | 0.15% | -30.7% | |
| SNOA | SONOMA PHARMACEUTICALS INC | $60,000 | -41.2% | 40,951 | 0.0% | 0.03% | -50.8% | |
| TLGT | TELIGENT INC NEW | $55,000 | +14.6% | 13,820 | 0.0% | 0.03% | -3.2% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-11-09
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMAZON COM INC COM | 30 | Q1 2022 | 44.1% |
| ESTABLISHMENT LABS HLDGS INC | 24 | Q2 2024 | 92.3% |
| ANTARES PHARMA INC | 19 | Q2 2019 | 4.0% |
| EAGLE PHARMACEUTICALS INC | 18 | Q1 2019 | 28.4% |
| HORIZON PHARMA PLC | 18 | Q1 2019 | 8.2% |
| HORIZON THERAPEUTICS PUB LTD | 17 | Q2 2023 | 6.5% |
| LIGAND PHARMACEUTICALS INC SHS CL B | 17 | Q4 2018 | 3.4% |
| BIOSPECIFICS TECHNOLOGIES CO | 16 | Q1 2019 | 8.4% |
| MICROSOFT CORP | 14 | Q1 2020 | 11.1% |
| CAMBREX CORP COM | 14 | Q1 2018 | 2.6% |
View JW Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| TerrAscend Corp. | January 02, 2024 | 57,621,892 | 20.1% |
| ESTABLISHMENT LABS HOLDINGS INC. | May 30, 2019 | 2,320,364 | 11.4% |
| EAGLE PHARMACEUTICALS, INC. | January 27, 2017 | 397,648 | 2.6% |
View JW Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-11-08 |
| 4 | 2024-09-16 |
| N-PX | 2024-08-26 |
| 13F-HR | 2024-08-08 |
| 4 | 2024-06-20 |
| 13F-HR | 2024-05-07 |
| 13F-HR | 2024-02-09 |
| 4 | 2024-01-02 |
| SC 13D/A | 2024-01-02 |
| 4 | 2023-12-26 |
View JW Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.